Synerkine Pharma
Pre-clinicalSynerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines.
Founded
2019
Focus
Biologics
About
Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines.
Funding History
2Total raised: $30M
Series A$25MForbionMar 15, 2022
Seed$5MBioGeneration VenturesJun 15, 2020
Company Info
TypePrivate
Founded2019
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile